跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIOLUX CONCENTRATE FOR SOLUTION FOR INJECTION 50MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
DIOLUX CONCENTRATE FOR SOLUTION FOR INJECTION 50MG/ML
Approved
THERAPEUTIC
DIOLUX CONCENTRATE FOR SOLUTION FOR INJECTION 50MG/ML
Gland Pharma Ltd.
🇸🇬 Health Sciences Authority
Approval Date
Aug 16, 2019
Approval ID
fbffa3236f653d02
Company
Gland Pharma Ltd.
Type
Therapeutic
Approval Details
Approval Id
fbffa3236f653d02
Drug Name
DIOLUX CONCENTRATE FOR SOLUTION FOR INJECTION 50MG/ML
Product Name
DIOLUX CONCENTRATE FOR SOLUTION FOR INJECTION 50MG/ML
Approval Number
SIN15782P
Approval Date
2019-08-16
Registrant
PHARMAKOE PTE. LTD.
Licence Holder
PHARMAKOE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
C01BD01
Atc Item Name
amiodarone
Pharma Manufacturer Name
PHARMAKOE PTE. LTD.
Company Detail Path
/organization/pharmakoe-pte-ltd
Active Ingredients
Amiodarone 47.3mg equivalent to Amiodarone hydrochloride
50mg/mL
AMIODARONE 47.3 MG EQUIVALENT TO AMIODARONE HYDROCHLORIDE
50 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 16, 2019
Approval ID
fbffa3236f653d02
Type
Therapeutic
Back to HSA Approvals
